MyAverix Finance
F · Healthcare
EXACT THERAP. AS NK 0004 (56F)
Biotechnology
EXACT THERAP. AS NK 0004 (56F) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 56F
EXACT THERAP. AS NK 0004 (56F) — FAQ
What is 56F's P/E ratio?
The price-to-earnings (P/E) ratio for EXACT THERAP. AS NK 0004 (56F) is 25.00 (data as of 2026-05-23).
Does EXACT THERAP. AS NK 0004 pay a dividend?
Dividend yield is not available in the current snapshot for EXACT THERAP. AS NK 0004 (56F). Check the MyAverix Finance app for the latest dividend data.
What sector is EXACT THERAP. AS NK 0004 in?
EXACT THERAP. AS NK 0004 (56F) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 56F listed on?
56F is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.